Results 181 to 190 of about 282,764 (294)

Advanced ECG heart age estimation applicable to both sinus and non-sinus rhythm associates with cardiovascular risk, cardiovascular morbidity, and survival [PDF]

Z. Al-Falahi, Todd T. Schlegel, Israel Lamela-Palencia, Annie Li, Erik B. Schelbert, L. Niklasson, Maren Maanja, Thomas Lindow, Martin Ugander   +8 more
openalex   +1 more source

Virtual healthcare compared to hospital care for acute and post‐acute illness in adults: A systematic review and meta‐analysis of randomized controlled trials

British Journal of Clinical Pharmacology, EarlyView.
Aim To evaluate the clinical effectiveness, cost‐effectiveness, quality of life (QoL) and patient/caregiver satisfaction associated with VWs/HaH vs. traditional inpatient care in adults with acute or post‐acute illness. Methods We conducted a systematic review and meta‐analysis of randomized controlled trials (RCTs), following PRISMA 2020 guidelines ...
Rana A. Malhis, Stuart E. Bond, Ahmed A. Sadeq, Rani Shatnawi, Barbara R. Conway, Syed Shahzad Hasan, Mamoon A. Aldeyab   +6 more
wiley   +1 more source

Enhanced prediction of left ventricular ejection fraction using electrocardiography with the addition of clinical metadata. [PDF]

Korean J Intern Med
Park HW, Kang T, Seo YH, Park JH.
europepmc   +1 more source

178 Fully automated coronary artery calcium score and risk categorization from non-ECG gated chest CT using deep learning and multiorgan segmentation: a validation study from national lung screening trial (NLST) [PDF]

Sudhir Rathore, Ashish Gautam, Prashant Raghav, Vijay Subramanya, Vikas Gupta, Samir Rathore, Srikanth Iyengar   +6 more
openalex   +1 more source

Effects of Renal and Hepatic Impairment on the Pharmacokinetics of Zilurgisertib

British Journal of Clinical Pharmacology, EarlyView.
Aim Small‐molecule activin receptor‐like kinase‐2 inhibitor zilurgisertib (INCB000928) is under investigation in a pivotal trial for the treatment of fibrodysplasia ossificans progressiva (FOP), an ultrarare genetic condition. This analysis assessed effects of renal and hepatic impairment on zilurgisertib pharmacokinetics.
Yan‐ou Yang, Yunlan Fang, Phillip Wang, Xiang Liu, Jay Getsy, Kevin Rockich   +5 more
wiley   +1 more source

Wearable devices for anxiety assessment: a systematic review. [PDF]

Commun Med (Lond)
Elgendi M, Markov K, Liu H, De Vos M, Khalaf K, Khandoker A, Jelinek HF, Goswami D, Menon C.   +8 more
europepmc   +1 more source

Portable Biomedical System for Acquisition, Display and Analysis of Cardiac Signals (SCG, ECG, ICG and PPG) [PDF]

Victor Gustavo Gómez, Ángel Guerra Garcia, Begoña Corral Ramos, Saúl Pérez, Jean Pierre Coll Velásquez, Pablo Daniel Bonaveri, Carlos Díaz   +6 more
openalex   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source

Precision Medicine for Electrocardiogram Interpretation: Clinical Relevance, Challenges, and Advances. [PDF]

Rev Cardiovasc Med
Namjouyan K, Sejdić E, Link MS, Pelliccia A, Glicksberg B, Trayanova N, Krittanawong C.   +6 more
europepmc   +1 more source

Hypnotic doses of fazamorexant induced less impairment on balance and cognition than zolpidem in healthy younger and elderly individualse

British Journal of Clinical Pharmacology, EarlyView.
Aims Fazamorexant is a dual orexin receptor antagonist being developed for the treatment of insomnia. This study aims to determine the dose‐exposure‐response relationship of single‐dose fazamorexant vs. zolpidem in young adult and elderly healthy Chinese volunteers. Methods This single‐centre, randomized, double‐blind, double‐dummy, placebo‐ and active‐
Chen Xia, Huang Xingxing, Jin Lu, Wang Ruwei   +3 more
wiley   +1 more source